Clinical trial
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA…
NCT00003974 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00003974 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma |
| Official title | An Evaluation of the Immunological Parameters Associated With a Skin-Test and Immunization of Lung and Mesothelioma Cancer Patients With Autologous Lung Tumor Associated Antigen: Characterization of the Patients' Cytolytic and Helper T Cell Reactivity for Identification of the Specific Antigen(s): A… |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer, Malignant Mesothelioma |
| Intervention type | Biological, Drug |
| Interventions | lung tumor associated antigen, DetoxPC, chemotherapy, cyclophosphamide |
| Enrollment | 20 |
| Start date | Aug 1, 1997 |
| Primary completion | Jun 1, 1998 |
| Completion | Nov 1, 2000 |
| First posted | Aug 20, 2004 |
| Last update posted | Mar 7, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: